- Home
- LEXX vs MTEN Comparison
LEXX vs MTEN Comparison
Compare LEXX & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- MTEN
- Stock Information
- Founded
- LEXX 2004
- MTEN 2015
- Country
- LEXX Canada
- MTEN China
- Employees
- LEXX N/A
- MTEN N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- MTEN Building Products
- Sector
- LEXX Health Care
- MTEN Industrials
- Exchange
- LEXX Nasdaq
- MTEN Nasdaq
- Market Cap
- LEXX 43.5M
- MTEN 39.0M
- IPO Year
- LEXX N/A
- MTEN 2024
- Fundamental
- Price
- LEXX $2.01
- MTEN $6.24
- Analyst Decision
- LEXX Strong Buy
- MTEN
- Analyst Count
- LEXX 2
- MTEN 0
- Target Price
- LEXX $11.00
- MTEN N/A
- AVG Volume (30 Days)
- LEXX 148.5K
- MTEN 112.7K
- Earning Date
- LEXX 01-10-2025
- MTEN 11-26-2024
- Dividend Yield
- LEXX N/A
- MTEN N/A
- EPS Growth
- LEXX N/A
- MTEN N/A
- EPS
- LEXX N/A
- MTEN 0.13
- Revenue
- LEXX $411,019.00
- MTEN $9,136,855.00
- Revenue This Year
- LEXX $82.02
- MTEN N/A
- Revenue Next Year
- LEXX $95.09
- MTEN N/A
- P/E Ratio
- LEXX N/A
- MTEN $48.05
- Revenue Growth
- LEXX 34.05
- MTEN 18.30
- 52 Week Low
- LEXX $1.20
- MTEN $1.81
- 52 Week High
- LEXX $6.85
- MTEN $9.87
- Technical
- Relative Strength Index (RSI)
- LEXX 26.93
- MTEN N/A
- Support Level
- LEXX $2.20
- MTEN N/A
- Resistance Level
- LEXX $2.42
- MTEN N/A
- Average True Range (ATR)
- LEXX 0.19
- MTEN 0.00
- MACD
- LEXX -0.00
- MTEN 0.00
- Stochastic Oscillator
- LEXX 7.27
- MTEN 0.00
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.